Annual Current Liabilities
$3.33 M
-$6.13 M-64.78%
December 31, 2023
Summary
- As of February 7, 2025, ENSC annual total current liabilities is $3.33 million, with the most recent change of -$6.13 million (-64.78%) on December 31, 2023.
- During the last 3 years, ENSC annual current liabilities has fallen by -$3.68 million (-52.45%).
- ENSC annual current liabilities is now -79.78% below its all-time high of $16.48 million, reached on December 31, 2021.
Performance
ENSC Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$2.80 M
+$1.50 M+114.43%
September 30, 2024
Summary
- As of February 7, 2025, ENSC quarterly total current liabilities is $2.80 million, with the most recent change of +$1.50 million (+114.43%) on September 30, 2024.
- Over the past year, ENSC quarterly current liabilities has dropped by -$531.20 thousand (-15.94%).
- ENSC quarterly current liabilities is now -83.00% below its all-time high of $16.48 million, reached on December 31, 2021.
Performance
ENSC Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ENSC Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.8% | -15.9% |
| 3 y3 years | -52.5% | -15.9% |
| 5 y5 years | -52.5% | -15.9% |
ENSC Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.8% | at low | -83.0% | +114.4% |
| 5 y | 5-year | -79.8% | at low | -83.0% | +114.4% |
| alltime | all time | -79.8% | at low | -83.0% | +114.4% |
Ensysce Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.80 M(+114.4%) |
| Jun 2024 | - | $1.31 M(-20.1%) |
| Mar 2024 | - | $1.64 M(-50.9%) |
| Dec 2023 | $3.33 M(-64.8%) | $3.33 M(+64.1%) |
| Sep 2023 | - | $2.03 M(-19.3%) |
| Jun 2023 | - | $2.52 M(-36.7%) |
| Mar 2023 | - | $3.98 M(-58.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $9.46 M(-42.6%) | $9.46 M(-20.5%) |
| Sep 2022 | - | $11.91 M(+44.4%) |
| Jun 2022 | - | $8.25 M(-6.3%) |
| Mar 2022 | - | $8.80 M(-46.6%) |
| Dec 2021 | $16.48 M(+135.1%) | $16.48 M(+134.4%) |
| Sep 2021 | - | $7.03 M(+74.5%) |
| Jun 2021 | - | $4.03 M(-42.5%) |
| Dec 2020 | $7.01 M | $7.01 M |
FAQ
- What is Ensysce Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Ensysce Biosciences?
- What is Ensysce Biosciences annual current liabilities year-on-year change?
- What is Ensysce Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Ensysce Biosciences?
- What is Ensysce Biosciences quarterly current liabilities year-on-year change?
What is Ensysce Biosciences annual total current liabilities?
The current annual current liabilities of ENSC is $3.33 M
What is the all time high annual current liabilities for Ensysce Biosciences?
Ensysce Biosciences all-time high annual total current liabilities is $16.48 M
What is Ensysce Biosciences annual current liabilities year-on-year change?
Over the past year, ENSC annual total current liabilities has changed by -$6.13 M (-64.78%)
What is Ensysce Biosciences quarterly total current liabilities?
The current quarterly current liabilities of ENSC is $2.80 M
What is the all time high quarterly current liabilities for Ensysce Biosciences?
Ensysce Biosciences all-time high quarterly total current liabilities is $16.48 M
What is Ensysce Biosciences quarterly current liabilities year-on-year change?
Over the past year, ENSC quarterly total current liabilities has changed by -$531.20 K (-15.94%)